- Home
- BMBL vs CRMD Comparison
BMBL vs CRMD Comparison
Compare BMBL & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMBL
- CRMD
- Stock Information
- Founded
- BMBL 2014
- CRMD 2006
- Country
- BMBL United States
- CRMD United States
- Employees
- BMBL 1200
- CRMD N/A
- Industry
- BMBL Computer Software: Prepackaged Software
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- BMBL Technology
- CRMD Health Care
- Exchange
- BMBL Nasdaq
- CRMD Nasdaq
- Market Cap
- BMBL 828.7M
- CRMD 738.4M
- IPO Year
- BMBL 2021
- CRMD 2010
- Fundamental
- Price
- BMBL $7.66
- CRMD $12.49
- Analyst Decision
- BMBL Hold
- CRMD Strong Buy
- Analyst Count
- BMBL 16
- CRMD 6
- Target Price
- BMBL $8.58
- CRMD $15.67
- AVG Volume (30 Days)
- BMBL 2.0M
- CRMD 1.3M
- Earning Date
- BMBL 02-25-2025
- CRMD 03-11-2025
- Dividend Yield
- BMBL N/A
- CRMD N/A
- EPS Growth
- BMBL N/A
- CRMD N/A
- EPS
- BMBL N/A
- CRMD N/A
- Revenue
- BMBL $1,083,632,000.00
- CRMD $12,262,234.00
- Revenue This Year
- BMBL $3.82
- CRMD N/A
- Revenue Next Year
- BMBL N/A
- CRMD $246.41
- P/E Ratio
- BMBL N/A
- CRMD N/A
- Revenue Growth
- BMBL 6.26
- CRMD 41184.20
- 52 Week Low
- BMBL $4.80
- CRMD $2.89
- 52 Week High
- BMBL $14.65
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- BMBL 44.17
- CRMD 70.88
- Support Level
- BMBL $7.59
- CRMD $7.91
- Resistance Level
- BMBL $8.51
- CRMD $13.09
- Average True Range (ATR)
- BMBL 0.44
- CRMD 0.70
- MACD
- BMBL -0.02
- CRMD 0.43
- Stochastic Oscillator
- BMBL 28.46
- CRMD 88.68
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.